U.S. market Closed. Opens in 1 day 5 hours 30 minutes

CGEM | Cullinan Oncology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/A18.94MN/AN/AN/A
Cost of Revenue310.00K93.00K53.00K62.00K70.00K43.00K
Gross Profit-310.00K-93.00K18.89M-62.00K-70.00K-43.00K
Operating Expenses191.09M132.14M86.90M60.34M22.27M14.59M
Selling, General & Admin42.49M40.19M29.15M17.12M5.48M5.00M
Research & Development148.16M91.95M57.75M43.21M16.79M9.58M
Other Operating Expenses440.00K57.00K-8.00K-11.00K-4.00KN/A
Operating Income-191.09M144.65M-67.95M-60.34M-22.27M-14.59M
Other Expenses / Income21.87M6.67M469.00K877.00K616.00K397.00K
Before Tax Income-169.22M151.32M-67.48M-59.46M-21.65M-14.19M
Income Tax Expenses-14.12M42.12M-2.44M-8.61M-1.62M397.00K
Net Income-153.16M111.21M-65.04M-50.85M-20.04M-14.19M
Interest ExpensesN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding41.51M45.16M44.29M43.52M43.52M11.45M
Diluted Shares Outstanding41.55M46.64M44.29M43.52M43.52M11.45M
EBITDA-190.34M151.41M-67.90M-60.27M-22.20M-14.54M
EBITDA Margin0.00%0.00%-358.45%0.00%0.00%0.00%
EBIT-167.28M153.34M-67.48M-59.46M-21.65M-13.79M
EBIT Margin0.00%0.00%-356.25%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙